Checkpoint Therapeutics' cosibelimab shows strong efficacy in treating cSCC. Learn why CKPT stock could see significant gains ...
Investors continued to see multiple shades of light red as biotechs continued to struggle in the wake of the postelection ...
The immediate aftermath of the nomination saw vaccine stock prices drop on account of Kennedy’s well-publicized views on ...
The Nasdaq Composite was headed for a fourth day in the red on Friday, according to Dow Jones Market Data. A pullback in shares of Big Tech giants has contributed to the weakness in the tech-heavy ...
U.S. stocks ended lower on Thursday, putting a little more daylight between them and the record territory claimed earlier in the week. Investors have been focused on what Donald Trump's second ...